BioCryst Pharmaceuticals News

BioCryst Pharmaceuticals | ARS: Annual Report to Security Holders

Apr 26 04:32

BioCryst Pharmaceuticals | DEFA14A: Others

Apr 26 04:27

BioCryst Pharmaceuticals | DEF 14A: Definitive information statements

Apr 26 04:22

BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Thackray Helen M.

Apr 3 04:27

BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director MILANO VINCENT

Mar 5 06:51

BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director HEGGIE THERESA

Mar 5 05:36

BioCryst Pharmaceuticals | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Feb 28 06:14

BioCryst Pharmaceuticals | 10-K: Annual report

Feb 28 05:16

BioCryst Pharmaceuticals | 8-K: BioCryst Reports Fourth Quarter and Full Year 2023 Financial Results and Upcoming Key Milestones

Feb 26 20:10

BioCryst Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Felix J. Baker(4.98%),Julian C. Baker(4.98%), etc.

Feb 15 06:47

BioCryst Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Avoro Capital Advisors LLC(6.4%),Behzad Aghazadeh(6.4%)

Feb 14 22:07

BioCryst Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(8.67%)

Feb 14 07:08

BioCryst Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(9.1%)

Jan 25 06:32

BioCryst Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION(6.24%)

Jan 25 02:10

BioCryst Pharmaceuticals | 8-K: Current report

Jan 18 13:00

BioCryst Pharmaceuticals | 8-K: Current report

Jan 8 13:00

BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Stonehouse Jon P

Jan 4 13:00

BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Thackray Helen M.

Dec 21, 2023 05:42

BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Stonehouse Jon P

Dec 21, 2023 05:40

BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Commercial Officer Gayer Charles K

Dec 21, 2023 05:38